Jennison Associates LLC Rubius Therapeutics, Inc. Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 07, 2020	SELL	$7.23 - $14.12 $3.14 Million - $6.14 Million	-434,550 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$7.85 - $15.75 $344,167 - $690,527	-43,843 Reduced 9.16%	434,550 $3.41 Million
Q2 2019 Aug 06, 2019	SELL	$13.5 - $19.94 $13,567 - $20,039	-1,005 Reduced 0.21%	478,393 $0
Q1 2019 May 10, 2019	BUY	$13.27 - $18.51 $23,912 - $33,355	1,802 Added 0.38%	479,398 $8.68 Million
Q4 2018 Feb 06, 2019	BUY	$13.83 - $22.97 $74,502 - $123,739	5,387 Added 1.14%	477,596 $7.68 Million
Q3 2018 Nov 08, 2018	BUY	$20.06 - $26.94 $9.47 Million - $12.7 Million	472,209 New	472,209 $11.3 Million

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.